APA (7th ed.) Citation

Luyten, J., & van Hoek, A. J. (2025). Reasons for excluding adverse events in cost-effectiveness analyses of vaccines: A survey amongst authors. Vaccine, 61, 127341. https://doi.org/10.1016/j.vaccine.2025.127341

Chicago Style (17th ed.) Citation

Luyten, Jeroen, and Albert Jan van Hoek. "Reasons for Excluding Adverse Events in Cost-effectiveness Analyses of Vaccines: A Survey Amongst Authors." Vaccine 61 (2025): 127341. https://doi.org/10.1016/j.vaccine.2025.127341.

MLA (9th ed.) Citation

Luyten, Jeroen, and Albert Jan van Hoek. "Reasons for Excluding Adverse Events in Cost-effectiveness Analyses of Vaccines: A Survey Amongst Authors." Vaccine, vol. 61, 2025, p. 127341, https://doi.org/10.1016/j.vaccine.2025.127341.